UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035856
Receipt number R000021610
Scientific Title Safety and efficacy of cisplatin plus paclitaxel in patients with uterine cervical cancer which has risk factors for recurrence
Date of disclosure of the study information 2019/02/12
Last modified on 2022/08/17 16:32:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and efficacy of cisplatin plus paclitaxel in patients with uterine cervical cancer which has risk factors for recurrence

Acronym

Safety and efficacy of cisplatin plus paclitaxel in patients with uterine cervical cancer which has risk factors for recurrence

Scientific Title

Safety and efficacy of cisplatin plus paclitaxel in patients with uterine cervical cancer which has risk factors for recurrence

Scientific Title:Acronym

Safety and efficacy of cisplatin plus paclitaxel in patients with uterine cervical cancer which has risk factors for recurrence

Region

Japan


Condition

Condition

Uterine cervical cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and tolerance of cisplatin plus paclitaxel as adjuvant chemotherapy in cervical cancer which has risk factors for recurrence

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

two years disease free survival rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

TP therapy (cicplatin, paclitaxel)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Female

Key inclusion criteria

Postoperative patients with uterine cervical cancer stage I-II.
(1)who are diagnosed as uterine cervical cancer pathologically.
(2)who are underwent radical hysterectomy and have risk factors for recurrens written below.
1. more than 1/2 invasion to cervical stroma and lymphovascular invasion
2. more than 2/3 invasion to cervical stroma
3. Lymph node metastasis
4. invasion to parametrium
(3)no history of treatment other than surgery for uterine cervical cancer
(4)age, over 20years old and under 75 years old.
(5)Performance Status: 0-1
(6)normal function of organ (bone marrow, heart,liver, kidney)
(7)written informed consent is obtained
(8)who can start chemotherapy within six weeks from the surgery.

Key exclusion criteria

(1) who has severe infection after operation.
(2)who has severe complicarion.
(3)who has other cancer.
(4)who has interstitial pneumonia or pulmonary fibrosis.
(5)who have ascirtes or pleural infussion which need treatment.
(6)who has the administration contraindication to cisplatin or paclitaxel.
(7)who is severe allergic to drug.
(8)who is considered inappropriate to this study by attending doctor.

Target sample size

125


Research contact person

Name of lead principal investigator

1st name Toshiyuki
Middle name
Last name Sumi

Organization

Osaka City University Graduate School of Medicine

Division name

Obstetrics and Gynecology

Zip code

545-8585

Address

1-4-3, Asahi-machi, Abeno-ku

TEL

06-6645-3862

Email

sumi-toshi@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Fukuda

Organization

Osaka City University Graduate School of Medicine

Division name

Obstetrics and Gynecology

Zip code

545-8585

Address

1-4-3, Asahi-machi, Abeno-ku

TEL

06-6645-3862

Homepage URL


Email

takeshif@med.osaka-cu.ac.jp


Sponsor or person

Institute

Department of Obstetrics and Gynecology Osaka City Iniversity Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Obstetrics and Gynecology Osaka City Iniversity Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Metropolitan University Hospital Certified Review Board

Address

1-2-7, Asahimachi, Abeno-ku, Osaka

Tel

06-6645-3456

Email

gr-a-knky-crb@omu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

75

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 08 Month 14 Day

Date of IRB

2015 Year 07 Month 22 Day

Anticipated trial start date

2015 Year 09 Month 01 Day

Last follow-up date

2022 Year 08 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 12 Day

Last modified on

2022 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021610


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name